Sign up to save your podcasts
Or
Share Considerations for Use of Two Newly Approved Drugs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Considerations for Use of Two Newly Approved Drugs
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
View all episodes
By Modern Optometry
5
1414 ratings
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
More shows like To the Point
View all
Power Hour Optometry
75 Listeners
Mind Pump: Raw Fitness Truth
11,772 Listeners
Defocus Media Podcast Network
55 Listeners
20/20 MONEY
78 Listeners
EyeCode Media
100 Listeners
The MOD Pod
5 Listeners
Four Eyes
19 Listeners
Optometry: The Ultimate O.D.
17 Listeners
Optometric Insights Media
20 Listeners
The Optometry Money Podcast
13 Listeners
The Dr. April Jasper Show
14 Listeners
EYE OWN A BUSINESS
16 Listeners
The Mel Robbins Podcast
20,794 Listeners
The 20/20 Podcast
7 Listeners
Eye Give a Damn!
17 Listeners